CEO: | Phil L'Huillier |
CFO: | Sath Nirmalananthan |
Chief Scientific Officer: | Lindy Durrant |
Deputy Chairman: | Susan Clement Davies |
Non-Executive Chairman: | Jean-Michel Cosséry |
Non-Executive Dir: | Ursula Ney, Florian Reinaud, Martin Diggle |
Address: | Bellhouse Building, Sanders Road, Oxford Science Park, Oxford, United Kingdom , OX4 4GD |
Website: | http://www.scancell.co.uk/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00B63D3314 |
Currency | UK Pounds |
Share Price | 9.25p |
Change Today | 0.15p |
% Change | 1.65 % |
52 Week High | 19.50 |
52 Week Low | 7.50 |
Volume | 119,982 |
Shares Issued | 1,036.78m |
Market Cap | £95.90m |
Beta | 0.03 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
14:54 | 9,739 @ 9.20p |
10:41 | 49,868 @ 9.00p |
09:06 | 2,000 @ 9.50p |
09:06 | 100 @ 9.50p |
09:06 | 65 @ 9.50p |
CFO | Sath Nirmalananthan |
CEO | Phil L'Huillier |
You are here: research